Showing results (91-100 of 333) with videos related to
Sort By:
Pageof 34
Deutsche Medizinische Wochenschrift (1946)|July 14, 2018
[Immuno-Oncology: A Brief Overview]Sebastian Kobold, Angela Krackhardt, Hans Schlösser, et al.International Journal of Molecular Sciences|May 28, 2020
The Role of Immune Checkpoints after Cellular TherapyFriederike Schmitz, Dominik Wolf, Tobias A W HolderriedJournal of Cellular and Molecular Medicine|December 17, 2004
Endothelial progenitor cells: a source for therapeutic vasculogenesis?Holger Rumpold, Dominik Wolf, Ruth Koeck, et al.International Journal of Molecular Sciences|June 2, 2021
EnvIRONmental Aspects in Myelodysplastic SyndromeVerena Petzer, Igor Theurl, Günter Weiss, et al.Frontiers in Immunology|June 20, 2018
CD8<sup>+</sup>HLADR<sup>+</sup> Regulatory T Cells Change With Aging: They Increase in Number, but Lose Checkpoint Inhibitory Molecules and Suppressive FunctionStella Lukas Yani, Michael Keller, Franz Leonard Melzer, et al.Blood|October 24, 2002
Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeysSieghart Sopper, Dagmar Nierwetberg, Astrid Halbach, et al.Neuroimage. Clinical|August 20, 2015
Altered whole-brain white matter networks in preclinical Alzheimer's diseaseFlorian Udo Fischer, Dominik Wolf, Armin Scheurich, et al.Frontiers in Aging Neuroscience|March 11, 2021
Structural Network Efficiency Predicts Resilience to Cognitive Decline in Elderly at Risk for Alzheimer's DiseaseFlorian U Fischer, Dominik Wolf, Oliver Tüscher, et al.Plos One|January 28, 2014
Association of structural global brain network properties with intelligence in normal agingFlorian U Fischer, Dominik Wolf, Armin Scheurich, et al.BMJ Case Reports|July 5, 2012
Durable complete remission in a patient with recurrent DLBCL receiving rituximab monotherapy after high-dose chemotherapy and autologous stem cell transplantationAndreas Pircher, Eva Maria Gassner, Michael Steurer, et al.Pageof 34